Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1Phase 1 1

Status

Completed 17Active not recruiting 5Terminated 4Recruiting 3Unknown 1Available 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 5

Conditions

Carcinoma, Renal Cell 7Gastrointestinal Stromal Tumors 5Urologic Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Carcinoma 2Uveal Melanoma 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymoma 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Kidney Diseases 1Hematologic Neoplasms 1Glioma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Sunitinib 5ripretinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Biopsy 2regorafenib 1binimetinib 1Temozolomide 1TAS-116 1Sorafenib 1Rogaratinib 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Midazolam 1Ipilimumab 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Stromal Tumors × Sunitinib × Clear all
NCT05208047 2026-05-22

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Cogent Biosciences, Inc.

Phase 3 Active not recruiting
482 enrolled
GastrointestinalSarcoma

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

NCT03673501 2026-02-05

INTRIGUE

Deciphera Pharmaceuticals, LLC

Phase 3 Active not recruiting
453 enrolled 20 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05245968 2026-01-20

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Taiho Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
78 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05734105 2025-12-17

INSIGHT

Deciphera Pharmaceuticals, LLC

Phase 3 Active not recruiting
54 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06208748 2025-10-31

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Sarcoma Alliance for Research through Collaboration

Phase 2 Active not recruiting
40 enrolled
GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡